Cargando…

circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis

BACKGROUND: Circular RNAs (circRNAs) regulate multiple malignant behaviors of various types of cancer. The role of circDNMT1, a newly identified circRNA, remains unknown in gastric cancer (GC). This study aimed to elucidate the underlying mechanisms of circDNMT1 in regulating GC progression. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hanghang, Cao, Bo, Zhao, Ruiyang, Li, Tian, Xu, Xingming, Cui, Hao, Deng, Huan, Gao, Jingwang, Wei, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197105/
https://www.ncbi.nlm.nih.gov/pubmed/35712504
http://dx.doi.org/10.3389/fonc.2022.817192
_version_ 1784727331202400256
author Li, Hanghang
Cao, Bo
Zhao, Ruiyang
Li, Tian
Xu, Xingming
Cui, Hao
Deng, Huan
Gao, Jingwang
Wei, Bo
author_facet Li, Hanghang
Cao, Bo
Zhao, Ruiyang
Li, Tian
Xu, Xingming
Cui, Hao
Deng, Huan
Gao, Jingwang
Wei, Bo
author_sort Li, Hanghang
collection PubMed
description BACKGROUND: Circular RNAs (circRNAs) regulate multiple malignant behaviors of various types of cancer. The role of circDNMT1, a newly identified circRNA, remains unknown in gastric cancer (GC). This study aimed to elucidate the underlying mechanisms of circDNMT1 in regulating GC progression. METHODS: microRNA (miRNA) and circRNA expression was detected by quantitative real-time PCR. Western blotting was performed to measure hypoxia inducible factor-1 alpha (HIF-1α) protein expression. Sanger sequencing, gel electrophoresis and fluorescence in situ hybridization were performed to identify the presence of circDNMT1. The clinicopathological features and overall survival of patients were analyzed based on circDNMT1 expression. The proliferation, migration and invasion of GC cells were determined by cell counting kit-8, 5-ethynyl-2’-deoxyuridine, wound healing and transwell assays. Glycolysis of GC cells was detected based on the levels of glucose uptake, the lactate acid, ATP and pyruvic acid production and the extracellular acidification and oxygen consumption rates. The binding sites between miR-576-3p and circDNMT1 or HIF-1α were predicted by online bioinformatic tools and were validated using RNA pull-down and luciferase reporter assays. Xenograft models were established to determine the effects of the circDNMT1/miR-576-3p/HIF-1α axis on GC growth and metastasis in vivo. RESULTS: circDNMT1 was successfully identified and shown to be overexpressed in GC tissues and cell lines. The expression levels of circDNMT1 were correlated with pathological T stage, pathological TNM stage and shorter survival time of GC patients. circDNMT1 knockdown inhibited the proliferation, migration, invasion and glycolysis of GC cells. circDNMT1 functioned as an oncogenic factor by sponging miR-576-3p. HIF-1α was negatively regulated by miR-576-3p via binding its mRNA 3’ untranslated region. circDNMT1 promoted malignant behaviors and metabolic reprogramming of GC by targeting the miR-576-3p/HIF-1α axis both in vitro and in vivo. CONCLUSION: These findings demonstrated that circDNMT1 knockdown inhibited GC proliferation, migration, invasion and glycolysis through sponging miR-576-3p/HIF-1α axis. circDNMT1 may be a novel target for GC treatment.
format Online
Article
Text
id pubmed-9197105
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91971052022-06-15 circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis Li, Hanghang Cao, Bo Zhao, Ruiyang Li, Tian Xu, Xingming Cui, Hao Deng, Huan Gao, Jingwang Wei, Bo Front Oncol Oncology BACKGROUND: Circular RNAs (circRNAs) regulate multiple malignant behaviors of various types of cancer. The role of circDNMT1, a newly identified circRNA, remains unknown in gastric cancer (GC). This study aimed to elucidate the underlying mechanisms of circDNMT1 in regulating GC progression. METHODS: microRNA (miRNA) and circRNA expression was detected by quantitative real-time PCR. Western blotting was performed to measure hypoxia inducible factor-1 alpha (HIF-1α) protein expression. Sanger sequencing, gel electrophoresis and fluorescence in situ hybridization were performed to identify the presence of circDNMT1. The clinicopathological features and overall survival of patients were analyzed based on circDNMT1 expression. The proliferation, migration and invasion of GC cells were determined by cell counting kit-8, 5-ethynyl-2’-deoxyuridine, wound healing and transwell assays. Glycolysis of GC cells was detected based on the levels of glucose uptake, the lactate acid, ATP and pyruvic acid production and the extracellular acidification and oxygen consumption rates. The binding sites between miR-576-3p and circDNMT1 or HIF-1α were predicted by online bioinformatic tools and were validated using RNA pull-down and luciferase reporter assays. Xenograft models were established to determine the effects of the circDNMT1/miR-576-3p/HIF-1α axis on GC growth and metastasis in vivo. RESULTS: circDNMT1 was successfully identified and shown to be overexpressed in GC tissues and cell lines. The expression levels of circDNMT1 were correlated with pathological T stage, pathological TNM stage and shorter survival time of GC patients. circDNMT1 knockdown inhibited the proliferation, migration, invasion and glycolysis of GC cells. circDNMT1 functioned as an oncogenic factor by sponging miR-576-3p. HIF-1α was negatively regulated by miR-576-3p via binding its mRNA 3’ untranslated region. circDNMT1 promoted malignant behaviors and metabolic reprogramming of GC by targeting the miR-576-3p/HIF-1α axis both in vitro and in vivo. CONCLUSION: These findings demonstrated that circDNMT1 knockdown inhibited GC proliferation, migration, invasion and glycolysis through sponging miR-576-3p/HIF-1α axis. circDNMT1 may be a novel target for GC treatment. Frontiers Media S.A. 2022-05-30 /pmc/articles/PMC9197105/ /pubmed/35712504 http://dx.doi.org/10.3389/fonc.2022.817192 Text en Copyright © 2022 Li, Cao, Zhao, Li, Xu, Cui, Deng, Gao and Wei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Hanghang
Cao, Bo
Zhao, Ruiyang
Li, Tian
Xu, Xingming
Cui, Hao
Deng, Huan
Gao, Jingwang
Wei, Bo
circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis
title circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis
title_full circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis
title_fullStr circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis
title_full_unstemmed circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis
title_short circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis
title_sort circdnmt1 promotes malignant progression of gastric cancer through targeting mir-576-3p/hypoxia inducible factor-1 alpha axis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197105/
https://www.ncbi.nlm.nih.gov/pubmed/35712504
http://dx.doi.org/10.3389/fonc.2022.817192
work_keys_str_mv AT lihanghang circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis
AT caobo circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis
AT zhaoruiyang circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis
AT litian circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis
AT xuxingming circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis
AT cuihao circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis
AT denghuan circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis
AT gaojingwang circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis
AT weibo circdnmt1promotesmalignantprogressionofgastriccancerthroughtargetingmir5763phypoxiainduciblefactor1alphaaxis